METHOD OF ANESTHETIC MANAGEMENT IN DEGREE III-IV OBESITY ONCOGYNAECOLOGIC PATIENTS Russian patent published in 2011 - IPC A61M23/00 A61K31/02 A61K31/4468 A61K31/452 A61K33/06 A61K33/08 A61P23/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to anesthesiology, and can be used as an anaesthesia care of surgeries in degree III-IV obesity oncogynaecologic patients with no evident cardiac and pulmonary decompensation. For this purpose, a base type of blood circulation is pre-determined. The patients with hyperkinetic blood circulation require general anaesthesia by introduction of sevoflurane 1.3-1.6 MAK; 2.2-2.5 vol. % fentanyl 1.5-1.8 mcg·kg·hour, myoplegia is performed by introduction of esmerone 0.3-0.33 mg·kg·hour. It is combined with continuous infusion of dalargin during the whole anaesthesia in dose 45-55 mcg·kg·hour. The patients with hypokinetic blood circulation require general anaesthesia that is combined with continuous infusion of dalargin 45-55 mcg·kg·hour during the whole anaesthesia and infusion of magnesium sulphate 0.12-0.15 mmole·kg of body weights.

EFFECT: method enables adequate, safe and managed anaesthesia in the case patients ensured by haemodynamic stabilisation by determined blood circulation type.

2 ex